{"basic_info": {"ticker": "2186", "exchange": "XHKG", "bloomberg_ticker": "2186 HK Equity", "name": "LUYE PHARMA GROUP LTD", "industry": "Pharmaceuticals", "name_chinese_simplified": "绿叶制药", "period": "2020", "market_value": 11761254400, "total_income": 5539641000, "ccy": "人民币元", "shariah_compliance_summary": "non-compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 5374551000, "business_income_over_total_income": 0.9701984298260482}, {"shariah_compliance": "unknown", "income": 165090000, "business_income_over_total_income": 0.029801570173951707}], "details": [{"business_activity_cn": "肿瘤药物", "business_activity_en": "Cancer drugs", "income": 2235178000, "business_income_over_total_income": 0.40348787944922787, "shariah_compliance": "compliant"}, {"business_activity_cn": "心血管系统药物", "business_activity_en": "Cardiovascular system drugs", "income": 1004474000, "business_income_over_total_income": 0.1813247464953054, "shariah_compliance": "compliant"}, {"business_activity_cn": "消化与代谢药物", "business_activity_en": "Digestion and metabolism of drugs", "income": 733414000, "business_income_over_total_income": 0.1323937778639446, "shariah_compliance": "compliant"}, {"business_activity_cn": "中枢神经系统药物", "business_activity_en": "Central nervous system drugs", "income": 1401485000, "business_income_over_total_income": 0.2529920260175704, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 165090000, "business_income_over_total_income": 0.029801570173951707, "shariah_compliance": "unknown"}, {"business_activity_cn": "未分配", "business_activity_en": "Unassigned", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.667211657552336, "shariah_compliance": "non-compliant", "amount_over_market_value": 0.667211657552336}]}